And then a 2021 meta-analysis of 8 studies showing that the cartilage increases but has no benefit whatsoever.
"The data from the included studies provide strong evidence to determine the effect of intra-articular sprifermin on joint structure in individuals with KOA and show no specific adverse effects. Nevertheless, intra-articular sprifermin did not likely have any positive effect on symptom alleviation."
I'm sure patients will be lining up....
Ann: Trading Halt, page-276
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
-0.005(1.96%) |
Mkt cap ! $85.70M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.0¢ | 24.0¢ | $39.92K | 160.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 110364 | 24.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 3297 | 2 |
View Market Depth
| Last trade - 13.27pm 30/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |